Review paper compares two leading pancreatic cancer drugs

by Tyrel Linkhorn,University of ToledoPotential biomarkers in nab-paclitaxel/gemcitabine (a), Folfirinox (b) regimens of drug metabolism and mechanism of action. (c) Macrophages induce gemcitabi

Updated on: May 07,2024

Review paper compares two leading pancreatic cancer drugs

by Tyrel Linkhorn,University of ToledoPotential biomarkers in nab-paclitaxel/gemcitabine (a), Folfirinox (b) regimens of drug metabolism and mechanism of action. (c) Macrophages induce gemcitabi

Updated on:May 07,2024

Gastroesophageal reflux disease causally linked to lung cancer

by Elana GotkineGastroesophageal reflux disease (GERD) is causally associated with lung cancer risk, according to a study published online Dec. 8 inCancer Medicine.Lin Li, from The Second Affili

Updated on: January 10,2024

Gastroesophageal reflux disease causally linked to lung cancer

by Elana GotkineGastroesophageal reflux disease (GERD) is causally associated with lung cancer risk, according to a study published online Dec. 8 inCancer Medicine.Lin Li, from The Second Affili

Updated on:January 10,2024

'Natural killers' may help treat advanced solid cancerous tumors

by Chris Adam,Purdue UniversityCredit: Purdue UniversityAn internal battle over oxygen can lead to major setbacks for people battling solid malignant tumors such as lung and brain cancers. Many

Updated on: April 01,2024

'Natural killers' may help treat advanced solid cancerous tumors

by Chris Adam,Purdue UniversityCredit: Purdue UniversityAn internal battle over oxygen can lead to major setbacks for people battling solid malignant tumors such as lung and brain cancers. Many

Updated on:April 01,2024

Study offers new insights into earliest stages of brain tumor development

by University of PlymouthCredit:EMBO Reports(2024). DOI: 10.1038/s44319-023-00017-1Scientists working to better understand and find a cure for brain tumors have made progress in ident

Updated on: March 20,2024

Study offers new insights into earliest stages of brain tumor development

by University of PlymouthCredit:EMBO Reports(2024). DOI: 10.1038/s44319-023-00017-1Scientists working to better understand and find a cure for brain tumors have made progress in ident

Updated on:March 20,2024

Molecular subtypes of advanced kidney cancer matter for treatment response

by Yale Cancer Center/Smilow Cancer HospitalCredit: Unsplash/CC0 Public DomainA combination of immunotherapy and targeted therapies show promise in managing metastatic renal cell carcinoma (RCC), the

Updated on: April 28,2024

Molecular subtypes of advanced kidney cancer matter for treatment response

by Yale Cancer Center/Smilow Cancer HospitalCredit: Unsplash/CC0 Public DomainA combination of immunotherapy and targeted therapies show promise in managing metastatic renal cell carcinoma (RCC), the

Updated on:April 28,2024

Training the immune system to prevent cancer—researchers discover paradigm-shifting approach

by Courtney Perrett,University of MissouriSA-4-1BBL treatment protected mice from developing lung tumors induced by NNK.AExperimental design, and treatment timeline.Female A/J

Updated on: January 26,2024

Training the immune system to prevent cancer—researchers discover paradigm-shifting approach

by Courtney Perrett,University of MissouriSA-4-1BBL treatment protected mice from developing lung tumors induced by NNK.AExperimental design, and treatment timeline.Female A/J

Updated on:January 26,2024

Musashi 1 in breast cancer: Implications for dormancy and survival in bone marrow

by Impact Journals LLCKey summary of findings. Shown is increased expression of PD-L1 and Msi 1 in CSCs. Credit:Aging(2023). DOI: 10.18632/aging.204620A new research paper titled "Inc

Updated on: January 10,2024

Musashi 1 in breast cancer: Implications for dormancy and survival in bone marrow

by Impact Journals LLCKey summary of findings. Shown is increased expression of PD-L1 and Msi 1 in CSCs. Credit:Aging(2023). DOI: 10.18632/aging.204620A new research paper titled "Inc

Updated on:January 10,2024

Researchers discover new brain tumor subtypes that may identify treatment for incurable brain cancer

by RCSI University of Medicine and Health SciencesTrend towards improved OS and increased response rate in TMEHighpatients following adjuvant treatment with pembrolizumab or PVSRIPO . A. TME com

Updated on: February 01,2024

Researchers discover new brain tumor subtypes that may identify treatment for incurable brain cancer

by RCSI University of Medicine and Health SciencesTrend towards improved OS and increased response rate in TMEHighpatients following adjuvant treatment with pembrolizumab or PVSRIPO . A. TME com

Updated on:February 01,2024

Mouth cancer cases hit new record in England and Scotland—what you need to know

by Justin Stebbing,The ConversationCredit: Pixabay/CC0 Public DomainCases of mouth cancer have reached a record high in England and Scotland, a newreport shows. Last year, there were more

Updated on: November 30,2024

Mouth cancer cases hit new record in England and Scotland—what you need to know

by Justin Stebbing,The ConversationCredit: Pixabay/CC0 Public DomainCases of mouth cancer have reached a record high in England and Scotland, a newreport shows. Last year, there were more

Updated on:November 30,2024

Researchers identify a new way to target treatment-resistant cancers

by Hayley Dunning,Imperial College LondonCredit: ICLAn international team of researchers has found a different way cancer becomes resistant to chemotherapy, suggesting a new target for drugs.Che

Updated on: June 19,2024

Researchers identify a new way to target treatment-resistant cancers

by Hayley Dunning,Imperial College LondonCredit: ICLAn international team of researchers has found a different way cancer becomes resistant to chemotherapy, suggesting a new target for drugs.Che

Updated on:June 19,2024

Avelumab plus axitinib significantly improve progression-free survival in untreated renal cell carcinoma

byEuropean Society for Medical OncologyCredit: CC0 Public DomainA combination of the immune checkpoint blocker, avelumab, plus the tyrosine kinase inhibitor (TKI), axitinib, significantly improv

Updated on: December 18,2023

Avelumab plus axitinib significantly improve progression-free survival in untreated renal cell carcinoma

byEuropean Society for Medical OncologyCredit: CC0 Public DomainA combination of the immune checkpoint blocker, avelumab, plus the tyrosine kinase inhibitor (TKI), axitinib, significantly improv

Updated on:December 18,2023

For metastatic prostate cancer, immunotherapy may have unexpected potential

byColumbia University Irving Medical CenterCredit:Cancer Cell(2023). DOI: 10.1016/j.ccell.2023.10.006Immunotherapy has been disappointing as a prostate cancer treatment, but a new Co

Updated on: January 26,2024

For metastatic prostate cancer, immunotherapy may have unexpected potential

byColumbia University Irving Medical CenterCredit:Cancer Cell(2023). DOI: 10.1016/j.ccell.2023.10.006Immunotherapy has been disappointing as a prostate cancer treatment, but a new Co

Updated on:January 26,2024